Catalya Information

Catalya is a pioneering Biotech company dedicated to transforming drug delivery and cell culture technologies. Our innovative excipients enhance bioavailability for a wide range of pharmaceutical actives, while our advanced polymer technology optimizes and scales adherent cell culture. Our mission focuses on improving therapeutic outcomes through targeted delivery systems for central nervous system (CNS) and systemic applications. Our polymeric excipient enhances absorption for both small molecules and biopharmaceuticals, via oral and nasal administration. At the same time, our polymer technology addresses the challenges of scaling adherent cell growth, supporting drug development and advancing regenerative medicine research. By integrating these innovative solutions, Catalya aims to revolutionize pharmaceutical delivery and cell culture practices, paving the way for improved healthcare outcomes, ultimately resulting in improved patient care.